These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29168185)

  • 121. Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer.
    Xu C; Tsai YH; Galbo PM; Gong W; Storey AJ; Xu Y; Byrum SD; Xu L; Whang YE; Parker JS; Mackintosh SG; Edmondson RD; Tackett AJ; Huang J; Zheng D; Earp HS; Wang GG; Cai L
    Nucleic Acids Res; 2021 May; 49(9):4971-4988. PubMed ID: 33849067
    [TBL] [Abstract][Full Text] [Related]  

  • 122. [High expression of MRPL13 promotes cell cycle progression and proliferation of gastric cancer cells by inhibiting p53 signaling to affect long-term prognosis].
    Wang L; Xia Y; Zhang Z; Liu X; Shi J; Wang Y; Li J; Zhnag X; Geng Z; Song X; Zuo L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1558-1566. PubMed ID: 37814870
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function.
    Hauck PM; Wolf ER; Olivos DJ; Batuello CN; McElyea KC; McAtarsney CP; Cournoyer RM; Sandusky GE; Mayo LD
    Mol Cancer Res; 2017 Nov; 15(11):1598-1607. PubMed ID: 28784612
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling.
    Weissmueller S; Manchado E; Saborowski M; Morris JP; Wagenblast E; Davis CA; Moon SH; Pfister NT; Tschaharganeh DF; Kitzing T; Aust D; Markert EK; Wu J; Grimmond SM; Pilarsky C; Prives C; Biankin AV; Lowe SW
    Cell; 2014 Apr; 157(2):382-394. PubMed ID: 24725405
    [TBL] [Abstract][Full Text] [Related]  

  • 125. p66α Suppresses Breast Cancer Cell Growth and Migration by Acting as Co-Activator of p53.
    Zhang Q; Zhang Y; Zhang J; Zhang D; Li M; Yan H; Zhang H; Song L; Wang J; Hou Z; Yang Y; Zou X
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944103
    [TBL] [Abstract][Full Text] [Related]  

  • 126. SENEBLOC, a long non-coding RNA suppresses senescence via p53-dependent and independent mechanisms.
    Xu CL; Sang B; Liu GZ; Li JM; Zhang XD; Liu LX; Thorne RF; Wu M
    Nucleic Acids Res; 2020 Apr; 48(6):3089-3102. PubMed ID: 32030426
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53.
    Liu Z; Yang Y; Sun X; Ma R; Zhang W; Wang W; Yang G; Wang H; Zhang J; Wang Y; Tian J
    Molecules; 2024 Feb; 29(3):. PubMed ID: 38338471
    [TBL] [Abstract][Full Text] [Related]  

  • 128. FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression.
    Guo F; Cheng X; Jing B; Wu H; Jin X
    Oncogene; 2022 Feb; 41(6):838-851. PubMed ID: 34975151
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation.
    Vernaza A; Cardus DF; Smith JL; Partridge V; Baker AL; Lewis EG; Zhang A; Zhao Z; Du L
    J Cancer; 2024; 15(5):1153-1168. PubMed ID: 38356706
    [TBL] [Abstract][Full Text] [Related]  

  • 130. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.
    Vennin C; Mélénec P; Rouet R; Nobis M; Cazet AS; Murphy KJ; Herrmann D; Reed DA; Lucas MC; Warren SC; Elgundi Z; Pinese M; Kalna G; Roden D; Samuel M; Zaratzian A; Grey ST; Da Silva A; Leung W; ; Mathivanan S; Wang Y; Braithwaite AW; Christ D; Benda A; Parkin A; Phillips PA; Whitelock JM; Gill AJ; Sansom OJ; Croucher DR; Parker BL; Pajic M; Morton JP; Cox TR; Timpson P
    Nat Commun; 2019 Aug; 10(1):3637. PubMed ID: 31406163
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Anti-proliferative and apoptotic effect of cannabinoids on human pancreatic ductal adenocarcinoma xenograft in BALB/c nude mice model.
    Le TQ; Meesiripan N; Sanggrajang S; Suwanpidokkul N; Prayakprom P; Bodhibukkana C; Khaowroongrueng V; Suriyachan K; Thanasitthichai S; Srisubat A; Surawongsin P; Rungsipipat A; Sakarin S; Rattanapinyopituk K
    Sci Rep; 2024 Mar; 14(1):6515. PubMed ID: 38499634
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Lactate Induces Tumor Progression via LAR Motif-Dependent Yin-Yang 1 Degradation.
    Du S; Chen X; Han X; Wang Y; Yu D; Li Y; Zhu C; Tong Y; Gao S; Wang J; Wei F; Cai Q
    Mol Cancer Res; 2024 Oct; 22(10):957-972. PubMed ID: 38888574
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Design, synthesis, and anti-cancer evaluation of C-14 arylcarbamate derivatives of andrographolide.
    Yang TC; Chiang YJ; Chiang PY; Chen HY; Zhuang KR; Wang YC; Lin CH; Lo LC; Fu SL
    Bioorg Med Chem; 2024 Jan; 98():117582. PubMed ID: 38171253
    [TBL] [Abstract][Full Text] [Related]  

  • 134. RNA polymerase I subunit D activated by Yin Yang 1 transcription promote cell proliferation and angiogenesis of colorectal cancer cells.
    Shan J; Liang Y; Yang Z; Chen W; Chen Y; Sun K
    Korean J Physiol Pharmacol; 2024 May; 28(3):265-273. PubMed ID: 38682174
    [TBL] [Abstract][Full Text] [Related]  

  • 135. New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma.
    Lee YS; Im J; Yang Y; Lee HJ; Lee MR; Woo SM; Park SJ; Kong SY; Kim JY; Hwang H; Kim YH
    J Proteome Res; 2024 Mar; 23(3):905-915. PubMed ID: 38293943
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Yin Yang 1 promotes aggressive cell growth in high-grade breast cancer by directly transactivating kinectin 1.
    Gao L; Zhou W; Xie N; Qiu J; Huang J; Zhang Z; Hong M; Xia J; Xu J; Zhao P; Fu L; Luo Y; Jiang J; Gong H; Wang J; Dai Y; Luo D; Zou C
    MedComm (2020); 2022 Sep; 3(3):e133. PubMed ID: 35811688
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Effects of methylation and transcription factor YY1 on ID2 expression in non-small cell lung carcinoma cells.
    Tseng YH; Chou WR; Liu WL; Dung ZX; Lin CH; Hsieh CH; Wang CC
    Am J Cancer Res; 2024; 14(5):2424-2438. PubMed ID: 38859862
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression.
    Wu L; Zhou Z; Yu Y; Cheng C; Zhou S; Yan Y; Yu B; Zhang Y; Liu Z
    Cell Death Dis; 2024 Feb; 15(2):137. PubMed ID: 38351178
    [TBL] [Abstract][Full Text] [Related]  

  • 139. A Nutrient-Deficient Microenvironment Facilitates Ferroptosis Resistance via the FAM60A-PPAR Axis in Pancreatic Ductal Adenocarcinoma.
    Pan H; Sun Y; Qian LH; Liao YN; Gai YZ; Huo YM; Li ZQ; Nie HZ
    Research (Wash D C); 2024; 7():0300. PubMed ID: 38314086
    [TBL] [Abstract][Full Text] [Related]  

  • 140. A naturally derived small molecule compound suppresses tumor growth and metastasis in mice by relieving p53-dependent repression of CDK2/Rb signaling and the Snail-driven EMT.
    Ren B; Li Y; DI L; Cheng R; Liu L; Li H; Li Y; Tang Z; Yan Y; Lu T; Fu R; Cheng Y; Wu Z
    Chin J Nat Med; 2024 Feb; 22(2):112-126. PubMed ID: 38342564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.